Harvard Bioscience, Inc. (HBIO) Tops Q1 EPS by 2c

Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q1 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $25.9 million, versus $26.1 million reported last year.

For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Optimum Communications gets NYSE non-compliance notice over stock price
• Reading (RDI) Tops Q2 EPS by 4c